|
|
|||
|
||||
OverviewBotulinum toxin was approved by the Food and Drug Administration in 2011 for neurogenic bladder and in 2013 for idiopathic overactive bladder (OAB). In this Special Issue, we address the question of where we stand with this therapy a decade later. Has it prevailed and been proven useful? Which techniques have become established, and how were they optimized? Are more practical ways of distribution on the way? What acceptance problems or obstacles to long-term use might exist among patients or doctors? What are the risks? Has the therapy gained a foothold in the outpatient sector? Full Product DetailsAuthor: Heinrich Schulte-BauklohPublisher: Mdpi AG Imprint: Mdpi AG Dimensions: Width: 17.00cm , Height: 1.30cm , Length: 24.40cm Weight: 0.499kg ISBN: 9783725863389ISBN 10: 3725863385 Pages: 138 Publication Date: 23 January 2026 Audience: General/trade , General Format: Hardback Publisher's Status: Active Availability: Available To Order We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||